Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity

Heart Failure With Preserved Ejection Fraction

(2023) Margaret M. Redfield et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Heart Failure With Preserved Ejection Fraction

(2023) Barry A. Borlaug et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Design and Baseline Characteristics of STEP-HFpEF Program Evaluating Semaglutide in Patients With Obesity HFpEF Phenotype

(2023) Mikhail N. Kosiborod et al.   JACC-Heart Failure

BNP: Biomarker Not Perfect in heart failure with preserved ejection fraction

(2022) Sanjiv J Shah   EUROPEAN HEART JOURNAL

Obesity and heart failure with preserved ejection fraction: new insights and pathophysiological targets

(2022) Barry A Borlaug et al.   CARDIOVASCULAR RESEARCH

Semaglutide improves cardiometabolic risk factors in adults with overweight or obesity: STEP 1 and 4 exploratory analyses

(2022) Mikhail N. Kosiborod et al.   DIABETES OBESITY & METABOLISM

Dapagliflozin for heart failure according to body mass index: the DELIVER trial

(2022) Carly Adamson et al.   EUROPEAN HEART JOURNAL

Effect of Dapagliflozin on Health Status in Patients With Preserved or Mildly Reduced Ejection Fraction

(2022) Mikhail N. Kosiborod et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Once-Weekly Semaglutide in Adults with Overweight or Obesity

(2021) John P.H. Wilding et al.   NEW ENGLAND JOURNAL OF MEDICINE

Epidemiology of Heart Failure

(2021) Véronique L. Roger   CIRCULATION RESEARCH

Obesity, venous capacitance, and venous compliance in heart failure with preserved ejection fraction

(2021) Hidemi Sorimachi et al.   EUROPEAN JOURNAL OF HEART FAILURE

Exercise Intolerance in Older Adults With Heart Failure With Preserved Ejection Fraction

(2021) Ambarish Pandey et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Empagliflozin, Health Status, and Quality of Life in Patients With Heart Failure and Preserved Ejection Fraction: The EMPEROR-Preserved Trial

(2021) Javed Butler et al.   CIRCULATION

Quality of life in heart failure with preserved ejection fraction: importance of obesity, functional capacity, and physical inactivity

(2020) Yogesh N.V. Reddy et al.   EUROPEAN JOURNAL OF HEART FAILURE

Evaluation and management of heart failure with preserved ejection fraction

(2020) Barry A. Borlaug   Nature Reviews Cardiology

Characterization of the Obese Phenotype of Heart Failure With Preserved Ejection Fraction: A RELAX Trial Ancillary Study

(2019) Yogesh N.V. Reddy et al.   MAYO CLINIC PROCEEDINGS

Adverse Renal Response to Decongestion in the Obese Phenotype of Heart Failure With Preserved Ejection Fraction

(2019) Yogesh N.V. Reddy et al.   JOURNAL OF CARDIAC FAILURE

Patients’ Willingness to Accept Mitral Valve Procedure-Associated Risks Varies Across Severity of Heart Failure Symptoms

(2019) Shelby D. Reed et al.   Circulation-Cardiovascular Interventions

Obesity and the Obesity Paradox in Heart Failure

(2018) Tamara B. Horwich et al.   PROGRESS IN CARDIOVASCULAR DISEASES

Regional Adipose Distribution and its Relationship to Exercise Intolerance in Older Obese Patients Who Have Heart Failure With Preserved Ejection Fraction

(2018) Mark J. Haykowsky et al.   JACC-Heart Failure

Physical Function, Frailty, Cognition, Depression, and Quality of Life in Hospitalized Adults ≥60 Years With Acute Decompensated Heart Failure With Preserved Versus Reduced Ejection Fraction

(2018) Haider J. Warraich et al.   Circulation-Heart Failure

Pivotal Role of Excess Intra-Abdominal Adipose in the Pathogenesis of Metabolic/Obese HFpEF

(2018) Dalane W. Kitzman et al.   JACC-Heart Failure

Heart Failure With Preserved, Borderline, and Reduced Ejection Fraction

(2017) Kevin S. Shah et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Role of Diastolic Stress Testing in the Evaluation for Heart Failure With Preserved Ejection FractionClinical Perspective

(2016) Masaru Obokata et al.   CIRCULATION

Impact of Spironolactone on Longitudinal Changes in Health-Related Quality of Life in the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist TrialCLINICAL PERSPECTIVE

(2016) Eldrin F. Lewis et al.   Circulation-Heart Failure

Effect of Caloric Restriction or Aerobic Exercise Training on Peak Oxygen Consumption and Quality of Life in Obese Older Patients With Heart Failure With Preserved Ejection Fraction

(2016) Dalane W. Kitzman et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Weight Loss in Obese Patients With Heart Failure

(2016) Elisabet Zamora et al.   Journal of the American Heart Association

Comparable Performance of the Kansas City Cardiomyopathy Questionnaire in Patients With Heart Failure With Preserved and Reduced Ejection Fraction

(2013) Susan M. Joseph et al.   Circulation-Heart Failure

Cardiac natriuretic peptides act via p38 MAPK to induce the brown fat thermogenic program in mouse and human adipocytes

(2012) Marica Bordicchia et al.   JOURNAL OF CLINICAL INVESTIGATION

6-Min Walk Test Provides Prognostic Utility Comparable to Cardiopulmonary Exercise Testing in Ambulatory Outpatients With Systolic Heart Failure

(2012) Daniel E. Forman et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

The Natriuretic Peptides and Fat Metabolism

(2012) Thomas J. Wang   NEW ENGLAND JOURNAL OF MEDICINE

Body Mass Index and Adverse Cardiovascular Outcomes in Heart Failure Patients With Preserved Ejection Fraction

(2011) Markus Haass et al.   Circulation-Heart Failure

Impact of the Look AHEAD Intervention on NT-pro Brain Natriuretic Peptide in Overweight and Obese Adults With Diabetes

(2011) Alain G. Bertoni et al.   Obesity

Efficacy and Safety of Exercise Training in Patients With Chronic Heart Failure

(2009) Christopher M. O’Connor et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION